The Potential Role of Extracorporeal Cytokine Removal in Hemodynamic Stabilization in Hyperinflammatory Shock

• Published in: Biomedicines Vol. 9; no. 7; p. 768
• Main Authors: Hawchar, Fatime, Rao, Cristina, Akil, Ali, Mehta, Yatin, Rugg, Christopher, Scheier, Joerg, Adamson, Harriet, Deliargyris, Efthymios, Molnar, Zsolt
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01-07-2021; MDPI
• Subjects: Blood pressure; Catecholamines; Cytokine storm; cytosorb therapy; decatecholaminization; Etiology; hemoadsorption; hemodynamic stabilization; hypeinflammation; Intensive care; Norepinephrine; Oxygen saturation; Pathophysiology; Review; Sepsis; shock; Shock (Circulatory)
• ISSN: 2227-9059; 2227-9059
• DOI: 10.3390/biomedicines9070768

Hemodynamic instability due to dysregulated host response is a life-threatening condition requiring vasopressors and vital organ support. Hemoadsorption with Cytosorb has proven to be effective in reducing cytokines and possibly in attenuating the devastating effects of the cytokine storm originating from the immune over-response to the initial insult. We reviewed the PubMed database to assess evidence of the impact of Cytosorb on norepinephrine needs in the critically ill. We further analyzed those studies including data on control cohorts in a comparative pooled analysis, defining a treatment effect as the standardized mean differences in relative reductions in vasopressor dosage at 24 h. The literature search returned 33 eligible studies. We found evidence of a significant reduction in norepinephrine requirement after treatment: median before, 0.55 (IQR: 0.39–0.90); after, 0.09 (0.00–0.25) μg/kg/min, p < 0.001. The pooled effect size at 24 h was large, though characterized by high heterogeneity. In light of the importance of a quick resolution of hemodynamic instability in the critically ill, further research is encouraged to enrich knowledge on the potentials of the therapy.